Cargando…
Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
The development of a wide range of novel antineoplastic therapies has improved the prognosis for patients with a wide range of malignancies, which has increased the number of cancer survivors substantially. Despite the oncological benefit, cancer survivors are exposed to short- and long-term adverse...
Autores principales: | van Dorst, Daan C.H., Dobbin, Stephen J.H., Neves, Karla B., Herrmann, Joerg, Herrmann, Sandra M., Versmissen, Jorie, Mathijssen, Ron H.J., Danser, A.H. Jan, Lang, Ninian N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011349/ https://www.ncbi.nlm.nih.gov/pubmed/33793337 http://dx.doi.org/10.1161/CIRCRESAHA.121.318051 |
Ejemplares similares
-
Hypertension Management in Emergency Departments
por: Miller, Joseph, et al.
Publicado: (2020) -
Education Research Training for Academic Emergency Medicine Educators
por: Mayersak, Ryanne J., et al.
Publicado: (2022) -
Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor‐Induced Blood Pressure Rise: A Clinical Cohort Study
por: van Dorst, Daan C. H., et al.
Publicado: (2022) -
Imaging Atherosclerosis
por: Tarkin, Jason M., et al.
Publicado: (2016) -
The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
por: Schrader, J, et al.
Publicado: (2009)